Prevalence of Non-Viral Bloodborne Pathogens Among Healthy Blood Donors in Western Mexico: Problems and Failures of Public Health Policy
Abstract
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- WHO. Screening Donated Blood for Transfusion-Transmissible Infections: Recommendations. In WHO Guidelines Approved by the Guidelines Review Committee; World Health Organization: Geneva, Switzerland, 2009. [Google Scholar]
- Guerrero-Garcia, J.J.; Zuniga-Magana, A.G.; Barrera-De Leon, J.C.; Magana-Duarte, R.; Ortuno-Sahagun, D. Retrospective Study of the Seroprevalence of HIV, HCV, and HBV in Blood Donors at a Blood Bank of Western Mexico. Pathogen 2021, 10, 878. [Google Scholar] [CrossRef]
- Bloch, E.M.; Krause, P.J.; Tonnetti, L. Preventing Transfusion-Transmitted Babesiosis. Pathogen 2021, 10, 1176. [Google Scholar] [CrossRef]
- Tonnetti, L.; Dodd, R.Y.; Foster, G.; Stramer, S.L. Babesia blood testing: The first-year experience. Transfusion 2022, 62, 135–142. [Google Scholar] [CrossRef]
- Hochberg, N.S.; Montgomery, S.P. Chagas Disease. Ann. Intern. Med. 2023, 176, ITC17–ITC32. [Google Scholar] [CrossRef]
- DOF. NORMA Oficial Mexicana NOM-253-SSA1-2012, Para la Disposición de Sangre Humana y sus Componentes con Fines Terapéuticos; Diario Oficial de la Federación; México; 2012; pp. 1–112. Available online: https://www.gob.mx/cnts/documentos/norma-oficial-mexicana-nom-253-ssa1-2012-para-la-disposicion-de-sangre-humana-y-sus-componentes-con-fines-terapeuticos (accessed on 19 November 2024).
- SSA. Enfermedades de Transmisión Sexual en el Adolescente y Adulto que Producen úlceras Genitales: Herpes, Sífilis, Chancroide, Linfogranuloma Venéreo y Granuloma Inguinal: Secretaría de Salud. 2009. Available online: http://www.cenetec-difusion.com/CMGPC/IMSS-094-08/ER.pdf (accessed on 19 November 2024).
- Kingston, M.; French, P.; Goh, B.; Goold, P.; Higgins, S.; Sukthankar, A.; Stott, C.; Turner, A.; Tyler, C.; Young, H. UK National Guidelines on the Management of Syphilis 2008. Int. J. STD AIDS 2008, 19, 729–740. [Google Scholar] [CrossRef]
- Guzman-Gomez, D.; Salas-Gonzalez, G.; Lopez-Monteon, A.; Welsh-Rodriguez, C.M.; Torres-Montero, J.; Dumonteil, E.; Waleckx, E.; Ramos-Ligonio, A. Risk factors for infestation by Triatoma dimidiata in a rural locality of Veracruz, Mexico, with active transmission of Trypanosoma cruzi: Weather and rain as factors. Trop. Med. Int. Health 2021, 26, 916–926. [Google Scholar] [CrossRef]
- Tunback, P. Syphilis, the forgotten disease. Lakartidningen 2021, 118, 21059. [Google Scholar]
- Bjornelius, E.; Krynitz, B. Gammal imitatör gör comeback—Tänk på syfilis vid oklar feber, svårbedömda exantem och svårförklarade allmänsymtom. Lakartidningen 2018, 115, 1–4. [Google Scholar]
- Sangrador-Deitos, M.V.; Cruz-Hernández, A.; González-Olvera, J.A.; Rodríguez-Hernández, L.A.; Sánchez-Cárdenas, C.D.; Torres-Salgado, F.G. Prevalence of serology for infectious diseases in blood donors during 17 years in Guanajuato, Mexico. Med. Interna de México 2020, 36, 15–20. [Google Scholar] [CrossRef]
- D’Aes, T.; Van de Sande, D.; De Buck, E.; Zachee, P.; Compernolle, V.; Vandekerckhove, P. Does cold storage of blood before transfusion prevent the transmission of syphilis? A systematic review and meta-analysis. Vox Sang. 2024, 119, 219–231. [Google Scholar] [CrossRef]
- Tamrakar, P.; Bett, C.; Molano, R.D.; Ayub, A.; Asher, D.M.; Gregori, L. Effect of storage on survival of infectious Treponema pallidum spiked in whole blood and platelets. Transfusion 2021, 61, 3181–3189. [Google Scholar] [CrossRef] [PubMed]
- Binnicker, M.J.; Jespersen, D.J.; Rollins, L.O. Direct comparison of the traditional and reverse syphilis screening algorithms in a population with a low prevalence of syphilis. J. Clin. Microbiol. 2012, 50, 148–150. [Google Scholar] [CrossRef] [PubMed]
- Potekaev, N.; Zhukova, O.; Khamaganova, I. False-Positive Serologic Reactions for Syphilis. In Bacterial Sexually Transmitted Infections—New Findings, Diagnosis, Treatment, and Prevention; Vică, M.L., Ed.; InTechOpen: London, UK, 2022. [Google Scholar]
- PAHO. Epidemiological Review of Syphilis in the Americas; PAHO: Washington, DC, USA, 2022. [Google Scholar]
- WHO. Global Health Sector Strategy on Sexually Transmitted Infections 2016–2021; World Health Organization: Geneva, Switzerland, 2016. [Google Scholar]
- Tsuboi, M.; Evans, J.; Davies, E.P.; Rowley, J.; Korenromp, E.L.; Clayton, T.; Taylor, M.M.; Mabey, D.; Chico, R.M. Prevalence of syphilis among men who have sex with men: A global systematic review and meta-analysis from 2000–20. Lancet Glob. Health 2021, 9, e1110–e1118. [Google Scholar] [CrossRef] [PubMed]
- Quintas, A.E.; Dias, C.C.; Cogle, A.D.C.; Cordeiro, L.; Sarmento, A. Seroprevalence of viral transfusion transmissible infections (HBsAg, anti-HCV, anti-HIV, Syphilis) and coinfection among healthy volunteer blood donors during 5-years in Luanda, Angola. Braz. J. Infect. Dis. 2023, 27, 103704. [Google Scholar] [CrossRef]
- Alharazi, T.; Alzubiery, T.K.; Alcantara, J.C.; Qanash, H.; Bazaid, A.S.; Altayar, M.A.; Aldarhami, A. Prevalence of Transfusion-Transmitted Infections (HCV, HIV, Syphilis and Malaria) in Blood Donors: A Large-Scale Cross-Sectional Study. Pathogens 2022, 11, 726. [Google Scholar] [CrossRef]
- Niederhauser, C.; Tinguely, C.; Stolz, M.; Vock, M.; El Dusouqui, S.A.; Gowland, P. Evolution of Blood Safety in Switzerland over the Last 25 Years for HIV, HCV, HBV and Treponema pallidum. Viruses 2022, 14, 2611. [Google Scholar] [CrossRef]
- Osei-Boakye, F.; Nkansah, C.; Appiah, S.K.; Abbam, G.; Derigubah, C.A.; Ukwah, B.N.; Usanga, V.U.; Ugwuja, E.I.; Chukwurah, E.F. Self-reported high-risk behavior among first-time and repeat replacement blood donors; a four-year retrospective study of patterns. PLoS ONE 2024, 19, e0308453. [Google Scholar] [CrossRef]
- Conti, G.; Notari, E.P.; Dodd, R.Y.; Kessler, D.; Custer, B.; Reik, R.; Lanteri, M.C.; Hailu, B.; Yang, H.; Stramer, S.L.; et al. Syphilis seroprevalence and incidence in US blood donors from 2020 to 2022. Transfusion 2024, 64, 325–333. [Google Scholar] [CrossRef]
- WHO. Blood Safety and Availability. Available online: https://www.who.int/news-room/fact-sheets/detail/blood-safety-and-availability (accessed on 19 November 2024).
- SSA. Boletín Epidemológico. Semana Epidemiológica 52. Secretaría de Salud; 2023. Available online: https://www.gob.mx/cms/uploads/attachment/file/879365/sem52.pdf (accessed on 19 November 2024).
- Busselman, R.E.; Hamer, S.A. Chagas Disease Ecology in the United States: Recent Advances in Understanding Trypanosoma cruzi Transmission Among Triatomines, Wildlife, and Domestic Animals and a Quantitative Synthesis of Vector–Host Interactions. Annu. Rev. Anim. Biosci. 2022, 10, 325–348. [Google Scholar] [CrossRef]
- Angheben, A.; Boix, L.; Buonfrate, D.; Gobbi, F.; Bisoffi, Z.; Pupella, S.; Gandini, G.; Aprili, G. Chagas disease and transfusion medicine: A perspective from non-endemic countries. Blood Transfus. 2015, 13, 540–550. [Google Scholar] [CrossRef]
- Perez-Molina, J.A.; Molina, I. Chagas disease. Lancet 2018, 391, 82–94. [Google Scholar] [CrossRef] [PubMed]
- Rojo-Medina, J.; Ruiz-Matus, C.; Salazar-Schettino, P.M.; Gonzalez-Roldan, J.F. Enfermedad de Chagas en Mexico. Gac. Medica de Mex. 2018, 154, 605–612. [Google Scholar] [CrossRef] [PubMed]
- Valente, J.D.; Silva, N.D.S.; Vasconcelos de Sousa, S.; Amaral, C.E.M.; Pinto, L.C. Seroprevalence of Trypanosoma cruzi infection among blood donors in the state of Para, Brazil. Transfus. Apher. Sci. 2023, 62, 103756. [Google Scholar] [CrossRef] [PubMed]
- Olivera, M.J.; Fory, J.A.; Porras, J.F.; Buitrago, G. Prevalence of Chagas disease in Colombia: A systematic review and meta-analysis. PLoS ONE 2019, 14, e0210156. [Google Scholar] [CrossRef] [PubMed]
- Ortega-Arroyo, A.; Flores-Chavez, M.D.; Puente-Alcaraz, J. Combined use of two rapid tests for the conclusive diagnosis of Chagas disease: A systematic scoping review. BMJ Open 2021, 11, e047825. [Google Scholar] [CrossRef]
- PAHO-WHO. Guidelines for the Diagnosis and Treatment of Chagas Disease; Pan American Health Organization: Washington, DC, USA, 2019. [Google Scholar]
- Rubach, M.P.; Halliday, J.E.; Cleaveland, S.; Crump, J.A. Brucellosis in low-income and middle-income countries. Curr. Opin. Infect. Dis. 2013, 26, 404–412. [Google Scholar] [CrossRef]
- Doganay, M.; Aygen, B.; Esel, D. Brucellosis due to blood transfusion. J. Hosp. Infect. 2001, 49, 151–152. [Google Scholar] [CrossRef]
- Al-Kharfy, T.M. Neonatal brucellosis and blood transfusion: Case report and review of the literature. Ann. Trop. Paediatr. 2001, 21, 349–352. [Google Scholar] [CrossRef]
- Gay, L.; Melenotte, C.; Lakbar, I.; Mezouar, S.; Devaux, C.; Raoult, D.; Bendiane, M.K.; Leone, M.; Mege, J.L. Sexual Dimorphism and Gender in Infectious Diseases. Front. Immunol. 2021, 12, 698121. [Google Scholar] [CrossRef]
- DOF. NORMA Oficial Mexicana NOM-022-SSA2-2012, Para la Prevención y Control de la Brucelosis en el Ser Humano. Diario Oficial de la Federación; México; 2012, 1–11. Available online: https://www.dof.gob.mx/nota_detalle.php?codigo=5258723&fecha=11/07/2012#gsc.tab=0 (accessed on 19 November 2024).
- Martin, K.; Wenlock, R.; Roper, T.; Butler, C.; Vera, J.H. Facilitators and barriers to point-of-care testing for sexually transmitted infections in low- and middle-income countries: A scoping review. BMC Infect. Dis. 2022, 22, 561. [Google Scholar] [CrossRef]
Sex | First-Time Donors | Repeat Donors | Total | |||
---|---|---|---|---|---|---|
Number of Donors (%) | Age Means (SD, CI 95%) | Number of Donors (%) | Age Means (SD, CI 95%) | Number of Donors (%) | Age Means (SD, CI 95%) | |
Men | 117,320 (62.90) | 33.85 (10.72, 33.79–33.91) | 29,546 (70.65) | 33.24 (10.08, 33.12–33.35) | 146,866 (64.32) | 33.93 (10.60, 33.88–33.98) |
Female | 69,189 (37.10) | 33.60 (10.82, 33.52–33.68) | 12,273 (29.35) | 34.17 (10.47, 33.98–34.35) | 81,462 (35.68) | 33.69 (10.77, 33.62–33.76) |
Total | 186,509 (100) | 33.76 (10.76, 33.71–33.81) | 41,819 (100) | 34.22 (10.20, 34.12–34.32) | 228,328 (100) | 33.84 (10.66, 33.80–33.88) |
Non-Viral Bloodborne Disease | Sex | Positive Cases (%) | Age Means (SD, CI 95%) | Prevalence (Cases/100,000) | CI 95% | Prevalence by Sex (Cases/100,000) | CI 95% | p |
---|---|---|---|---|---|---|---|---|
Syphilis | Total | 478 (100) | 36.34 (11.01, 35.35–37.33) | 209 | 191–229 | 209 | 191–229 | 0.4731 |
Men | 315 (65.90) | 37.01 (11.38, 35.75–38.27) | 138 | 124–154 | 214 | 192–240 | ||
Female | 163 (34.10) | 35.05 (10.18, 33.48–36.62) | 71 | 61–83 | 200 | 172–233 | ||
Chagas | Total | 83 (100) | 38.53 (10.31, 36.28–40.78) | 36 | 29–45 | 36 | 29–45 | 0.7449 |
Men | 52 (62.65) | 39.27 (10.15, 36.44–42.10) | 23 | 17–30 | 35 | 27–46 | ||
Female | 31 (37.35) | 37.29 (10.50, 33.44–41.14) | 14 | 10–19 | 38 | 27–54 | ||
Brucellosis | Total | 121 (100) | 35.36 (9.88, 33.58–37.14) | 53 | 44–64 | 53 | 44–64 | 0.0033 |
Men | 62 (51.24) | 34.63 (10.44, 31.98–37.28) | 27 | 21–35 | 42 | 33–54 | ||
Female | 59 (48.76) | 36.12 (9.28, 33.70–38.54) | 26 | 20–33 | 72 | 56–93 |
First-Time Donors | |||||||
---|---|---|---|---|---|---|---|
Non-Viral Bloodborne Disease | Sex | Positive Cases (%) | Age Means (SD, CI 95%) | Prevalence (Cases/100,000) | IC 95% | Prevalence BY Sex (Cases/100,000) | IC 95% |
Syphilis | Men | 292 (66.21) | 37.12 (11.49, 35.80–38.44) | 157 | 1.40–1.76 | 249 | 222–280 |
Female | 149 (33.79) | 34.91 (10.30, 33.24–36.58) | 80 | 0.68–0.94 | 215 | 184–253 | |
Total | 441 (100) | 36.38 (11.14, 35.34–37.42) | 236 | 2.15–2.60 | 236 | 215–260 | |
Chagas | Men | 49 (64.47) | 39.63 (10.20, 36.70–42.56) | 26 | 0.20–0.35 | 42 | 32–55 |
Female | 27 (35.53) | 36.81 (9.19, 33.17–40.44) | 14 | 0.10–0.21 | 39 | 27–57 | |
Total | 76 (100) | 38.63 (9.88, 36.37–40.89) | 41 | 0.32–0.51 | 41 | 32–51 | |
Brucellosis | Men | 49 (51.58) | 33.76 (9.75, 30.96–36.56) | 26 | 0.20–0.35 | 42 | 32–55 |
Female | 46 (48.42) | 36.46 (9.85, 33.53–39.38) | 25 | 0.18–0.33 | 66 | 50–89 | |
Total | 95 (100) | 35.06 (9.84, 33.06–37.06) | 51 | 0.42–0.62 | 51 | 42–62 | |
Repeat Donors | |||||||
Non-Viral Bloodborne Disease | Sex | Positive Cases (%) | Age Means (SD, CI 95%) | Prevalence (Cases/1000) | IC 95% | Prevalence by Sex (Cases/1000) | IC 95% |
Syphilis | Men | 23 (62.16) | 35.57 (10.04, 31.23–39.91) | 55 | 0.37–0.82 | 78 | 0.52–1.17 |
Female | 14 (37.84) | 36.50 (8.97, 31.32–41.68) | 33 | 0.20–0.56 | 114 | 0.68–1.91 | |
Total | 37 (100) | 35.92 (9.53, 32.74–39.10) | 88 | 0.64–1.22 | 88 | 0.64–1.22 | |
Chagas | Men | 3 (42.86) | 33.33 (8.50, 12.21–54.44) | 07 | 0.02–0.21 | 10 | 0.03–0.30 |
Female | 4 (57.14) | 40.50 (18.84, 10.52–70.48) | 10 | 0.04–0.24 | 33 | 0.13–0.84 | |
Total | 7 (100) | 37.43 (14.71, 2.82–51.03) | 17 | 0.08–0.34 | 17 | 0.08–0.34 | |
Brucellosis | Men | 13 (50.00) | 37.92 (12.61, 30.30–45.54) | 31 | 0.18–0.53 | 44 | 0.26–0.75 |
Female | 13 (50.00) | 34.92 (7.15, 30.60–39.24) | 31 | 0.18–0.53 | 106 | 0.62–1.81 | |
Total | 26 (100) | 36.42 (10.16, 32.32–40.52) | 62 | 0.42–0.91 | 62 | 0.42–0.91 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Guerrero-García, J.d.J.; Flores-González, A.; Sánchez-Sánchez, A.M.; Magaña-Duarte, R.; Mireles-Ramírez, M.A.; Ortiz-Lazareno, P.C.; Sierra Díaz, E.; Ortuño-Sahagún, D. Prevalence of Non-Viral Bloodborne Pathogens Among Healthy Blood Donors in Western Mexico: Problems and Failures of Public Health Policy. Pathogens 2024, 13, 1027. https://doi.org/10.3390/pathogens13121027
Guerrero-García JdJ, Flores-González A, Sánchez-Sánchez AM, Magaña-Duarte R, Mireles-Ramírez MA, Ortiz-Lazareno PC, Sierra Díaz E, Ortuño-Sahagún D. Prevalence of Non-Viral Bloodborne Pathogens Among Healthy Blood Donors in Western Mexico: Problems and Failures of Public Health Policy. Pathogens. 2024; 13(12):1027. https://doi.org/10.3390/pathogens13121027
Chicago/Turabian StyleGuerrero-García, José de Jesús, Alejandra Flores-González, Alma Marina Sánchez-Sánchez, Rafael Magaña-Duarte, Mario Alberto Mireles-Ramírez, Pablo Cesar Ortiz-Lazareno, Erick Sierra Díaz, and Daniel Ortuño-Sahagún. 2024. "Prevalence of Non-Viral Bloodborne Pathogens Among Healthy Blood Donors in Western Mexico: Problems and Failures of Public Health Policy" Pathogens 13, no. 12: 1027. https://doi.org/10.3390/pathogens13121027
APA StyleGuerrero-García, J. d. J., Flores-González, A., Sánchez-Sánchez, A. M., Magaña-Duarte, R., Mireles-Ramírez, M. A., Ortiz-Lazareno, P. C., Sierra Díaz, E., & Ortuño-Sahagún, D. (2024). Prevalence of Non-Viral Bloodborne Pathogens Among Healthy Blood Donors in Western Mexico: Problems and Failures of Public Health Policy. Pathogens, 13(12), 1027. https://doi.org/10.3390/pathogens13121027